Trial
NCT03805178
Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and Desensitization
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Duke University
Collaborators
Bristol-Myers Squibb
Condition
Lung Transplant Rejection
Intervention
Belatacept
Why stopped
Not activated at Duke
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-05-02